• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身炎症生物标志物之战

Battle of the Biomarkers of Systemic Inflammation.

作者信息

Stec-Martyna Emilia, Wojtczak Karolina, Nowak Dariusz, Stawski Robert

机构信息

Research Laboratory CoreLab, Medical University of Lodz, 6/8 Mazowiecka St., 92-215 Lodz, Poland.

Department of Clinical Physiology, Medical University of Lodz, 92-215 Lodz, Poland.

出版信息

Biology (Basel). 2025 Apr 18;14(4):438. doi: 10.3390/biology14040438.

DOI:10.3390/biology14040438
PMID:40282303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12024891/
Abstract

Systemic inflammation is monitored with various biomarkers; of these, C-reactive protein (CRP) is widely used due to its cost effectiveness and widespread implementation. However, its lack of specificity and delayed kinetics have directed interest in cell-free DNA (cfDNA), which offers rapid responses to cellular damage. Our review compares the use of CRP and cfDNA in myocardial infarction, sepsis, and physical exercise, focusing on their origins, kinetics, and clinical utility. cfDNA release from apoptotic or damaged cells increases within minutes to hours, providing an early marker of cellular stress. In myocardial infarction, cfDNA peaks early, indicating acute injury, while CRP rises later, reflecting prolonged inflammation. In sepsis, cfDNA correlates strongly with disease severity and prognosis, outperforming CRP in early diagnosis. During physical exercise, cfDNA offers an immediate picture of cellular stress, whereas CRP's delayed response limits its utility in this context. The interaction between CRP and cfDNA suggests their combined application could improve diagnostic accuracy and prognostic assessments. As cfDNA testing becomes more widely available, researchers will need to develop standardized protocols and determine how it can best complement CRP measurements in clinical practice. This approach offers promise for improving the management of systemic inflammation across diverse medical conditions.

摘要

全身炎症通过多种生物标志物进行监测;其中,C反应蛋白(CRP)因其成本效益高且应用广泛而被广泛使用。然而,其缺乏特异性和动力学延迟促使人们对游离DNA(cfDNA)产生兴趣,cfDNA对细胞损伤能做出快速反应。我们的综述比较了CRP和cfDNA在心肌梗死、脓毒症和体育锻炼中的应用,重点关注它们的来源、动力学和临床效用。凋亡或受损细胞释放的cfDNA在数分钟至数小时内增加,提供细胞应激的早期标志物。在心肌梗死中,cfDNA早期达到峰值,表明急性损伤,而CRP稍后升高,反映炎症持续时间延长。在脓毒症中,cfDNA与疾病严重程度和预后密切相关,在早期诊断方面优于CRP。在体育锻炼期间,cfDNA能即时反映细胞应激情况,而CRP的延迟反应限制了其在此情况下的效用。CRP与cfDNA之间的相互作用表明,它们联合应用可提高诊断准确性和预后评估。随着cfDNA检测的应用越来越广泛,研究人员需要制定标准化方案,并确定其在临床实践中如何能最好地补充CRP测量。这种方法有望改善各种医疗状况下全身炎症的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12024891/6618a4ad37e9/biology-14-00438-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12024891/f5f05ae8ed28/biology-14-00438-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12024891/dcda6901b3f9/biology-14-00438-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12024891/6618a4ad37e9/biology-14-00438-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12024891/f5f05ae8ed28/biology-14-00438-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12024891/dcda6901b3f9/biology-14-00438-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12024891/6618a4ad37e9/biology-14-00438-g003.jpg

相似文献

1
Battle of the Biomarkers of Systemic Inflammation.全身炎症生物标志物之战
Biology (Basel). 2025 Apr 18;14(4):438. doi: 10.3390/biology14040438.
2
Cell Free DNA and Procalcitonin as Early Markers of Complications in ICU Patients with Multiple Trauma and Major Surgery.游离DNA和降钙素原作为多发伤和大手术ICU患者并发症的早期标志物
Clin Lab. 2016 Dec 1;62(12):2395-2404. doi: 10.7754/Clin.Lab.2016.160615.
3
Circulating cell-free DNA: an up-coming molecular marker in exercise physiology.循环游离 DNA:运动生理学中的一个新兴分子标志物。
Sports Med. 2012 Jul 1;42(7):565-86. doi: 10.2165/11631380-000000000-00000.
4
Cell-free DNA: a metabolic byproduct with diagnostic and prognostic potential in rheumatic disorders.游离DNA:一种在风湿性疾病中具有诊断和预后潜力的代谢副产物。
Front Pharmacol. 2025 Feb 11;16:1537934. doi: 10.3389/fphar.2025.1537934. eCollection 2025.
5
Early and Late Responses of Cultured Human Mesenchymal Stem Cells (MSCs) to Cell-free DNA (cfDNA) in Patients With Acute Myocardial Infarction.急性心肌梗死患者培养的人间充质干细胞(MSCs)对游离DNA(cfDNA)的早期和晚期反应
Front Biosci (Landmark Ed). 2025 Mar 31;30(4):28255. doi: 10.31083/FBL28255.
6
Prognostic utility and characterization of cell-free DNA in patients with severe sepsis.严重脓毒症患者游离DNA的预后效用及特征分析
Crit Care. 2012 Aug 13;16(4):R151. doi: 10.1186/cc11466.
7
Cell-free DNA release under psychosocial and physical stress conditions.在心理社会和身体应激条件下释放的无细胞 DNA。
Transl Psychiatry. 2018 Oct 29;8(1):236. doi: 10.1038/s41398-018-0264-x.
8
Cell-free DNA in patients with sepsis: long term trajectory and association with 28-day mortality and sepsis-associated acute kidney injury.脓毒症患者的游离 DNA:长期轨迹与 28 天死亡率和脓毒症相关急性肾损伤的关系。
Front Immunol. 2024 May 13;15:1382003. doi: 10.3389/fimmu.2024.1382003. eCollection 2024.
9
Cell-free DNA kinetics in response to muscle-damaging exercise: A drop jump study.响应肌肉损伤性运动的游离DNA动力学:一项纵跳研究。
Exp Physiol. 2024 Aug;109(8):1341-1352. doi: 10.1113/EP091986. Epub 2024 Jun 14.
10
Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases.游离细胞 DNA 作为心血管疾病的诊断和预后标志物。
Clin Chim Acta. 2020 Apr;503:145-150. doi: 10.1016/j.cca.2020.01.013. Epub 2020 Jan 21.

本文引用的文献

1
Methodological influences on circulating cell-free-mitochondrial and nuclear DNA concentrations in response to chronic stress.方法学对循环游离线粒体DNA和核DNA浓度响应慢性应激的影响。
Mol Biol Rep. 2025 Mar 13;52(1):303. doi: 10.1007/s11033-025-10369-7.
2
Unveiling the impact of corticosteroid therapy on liquid biopsy-detected cell-free DNA levels in meningioma and glioblastoma patients.揭示皮质类固醇疗法对脑膜瘤和胶质母细胞瘤患者液体活检检测到的游离DNA水平的影响。
J Liq Biopsy. 2024 Mar 20;5:100149. doi: 10.1016/j.jlb.2024.100149. eCollection 2024 Sep.
3
C-reactive protein levels and outcomes in infarct-related cardiogenic shock: data from the ECLS-SHOCK trial.
梗死相关心源性休克中C反应蛋白水平与预后:来自ECLS-SHOCK试验的数据
Eur Heart J Acute Cardiovasc Care. 2025 Feb 20;14(2):59-70. doi: 10.1093/ehjacc/zuae148.
4
Measurement of Pancreatic Stone Protein Compared with C-Reactive Protein and Procalcitonin in the Diagnosis of Sepsis in an Intensive Care Unit: A Systematic Review.重症监护病房中胰石蛋白与C反应蛋白及降钙素原在脓毒症诊断中的比较测量:一项系统评价
Malays J Med Sci. 2024 Oct;31(5):32-40. doi: 10.21315/mjms2024.31.5.3. Epub 2024 Oct 8.
5
Distinct methylome profile of cfDNA in AMI patients reveals significant alteration in cAMP signaling pathway genes regulating cardiac muscle contraction.cfDNA 在 AMI 患者中呈现独特的甲基化谱,表明调节心肌收缩的 cAMP 信号通路基因发生显著改变。
Clin Epigenetics. 2024 Oct 16;16(1):144. doi: 10.1186/s13148-024-01755-2.
6
Cell-free DNA kinetics in response to muscle-damaging exercise: A drop jump study.响应肌肉损伤性运动的游离DNA动力学:一项纵跳研究。
Exp Physiol. 2024 Aug;109(8):1341-1352. doi: 10.1113/EP091986. Epub 2024 Jun 14.
7
Survival outcomes correlate with the level of cell-free circulating DNA in ST-elevation myocardial infarction.生存结果与ST段抬高型心肌梗死中游离循环DNA的水平相关。
J Res Med Sci. 2024 Feb 23;29:8. doi: 10.4103/jrms.jrms_335_22. eCollection 2024.
8
The Trend of C-Reactive Protein After Corticosteroid Therapy in COVID-19 Patients Admitted to IGIMS, Patna.巴特那IGIMS收治的COVID-19患者接受皮质类固醇治疗后C反应蛋白的变化趋势
Cureus. 2024 Jan 2;16(1):e51499. doi: 10.7759/cureus.51499. eCollection 2024 Jan.
9
Cell-free DNA as diagnostic and prognostic biomarkers for adult sepsis: a systematic review and meta-analysis.游离 DNA 作为成人脓毒症的诊断和预后生物标志物的系统评价和荟萃分析。
Sci Rep. 2023 Nov 10;13(1):19624. doi: 10.1038/s41598-023-46663-2.
10
Interleukin 6: at the interface of human health and disease.白细胞介素 6:在人类健康与疾病的交界处。
Front Immunol. 2023 Sep 28;14:1255533. doi: 10.3389/fimmu.2023.1255533. eCollection 2023.